CBD Therapy Seeds

CBD Therapy is a feminized cultivar presented by Kiwi Seed Bank with a balanced 50% sativa and 50% indica profile. Its reported specifications emphasise CBD, a fruity-sweet flavour direction and a combination of humulene and linalool. Catalogue figures can vary between plants and growing environments, so they are best used for comparison rather than as guaranteed measurements.

Genetics & effects

The specific parentage of CBD Therapy is not established. Its stated 50% sativa and 50% indica composition places it at the midpoint of those broad cultivar categories without suggesting that every plant will develop or feel identical.

Reported cannabinoid figures are 10–14% CBD and 0.3–0.5% THC. These ranges describe the catalogue profile only and should not be read as a fixed ratio for every harvest. Experiences are subjective, but CBD Therapy is commonly characterised as calming, happy and relaxed. Aroma and flavour notes lean fruity and sweet, while the listed terpenes are humulene and linalool.

Explore feminised seeds, cbd seeds, the New Zealand grow guide, and the planting calendar.

Growing in

CBD Therapy is listed at a beginner difficulty level and associated with a temperate climate. This makes its specifications approachable for comparison, although individual performance still depends on the growing environment and plant variation. No established indoor or outdoor height range is available, so growers comparing space requirements should avoid assuming a compact or tall structure.

The reported flowering period is 8–10 weeks. This figure refers specifically to flowering and does not represent the plant’s complete life cycle. Time spent before flowering is not established in the available specifications.

Indoor

For indoor cultivation, the reported yield is 400–500 g/m². This is a catalogue range rather than a promised result. Available space, environmental consistency and normal plant-to-plant differences may all influence the final harvest. As height is unspecified, the cultivar is best compared using its documented flowering window, cannabinoid profile and yield range rather than an assumed indoor size.

Outdoor

Outdoor specifications identify a temperate climate, but they do not establish suitability for every New Zealand location. Conditions can differ considerably between northern and southern areas, as well as between coastal and inland settings. In the southern hemisphere, spring runs from September to November, summer from December to February and autumn from March to May. These seasonal markers provide local context, not a fixed planting or harvest timetable.

The reported outdoor yield is 500–550 g/plant. Outdoor height and exact seasonal timing are not established. Local daylight, exposure and year-to-year weather variation may affect how individual plants progress.

Harvest

CBD Therapy’s key harvest comparison points are its 8–10-week flowering period, reported indoor yield of 400–500 g/m² and reported outdoor yield of 500–550 g/plant. The expected profile centres on fruity and sweet notes, with humulene and linalool listed among its terpenes. Because these are reported catalogue specifications, actual cannabinoid levels, flavour expression, timing and yield may vary.